📰 Newspapers

Ksh800,000 cancer treatment benefit remains unchanged, SHA clarifies

Ksh800,000 cancer treatment benefit remains unchanged, SHA clarifies

SHA CEO Dr Mercy Mwangangi says the recent changes affect how cancer treatment is approved and priced, but do not reduce the approved benefit.

The Social Health Authority (SHA) says cancer patients will continue receiving treatment cover of up to Ksh800,000 despite recent changes to treatment approvals.

In a notice issued by Chief Executive Officer Dr Mercy Mwangangi, SHA clarified that the changes affect how cancer treatment is approved and priced, but do not reduce the approved benefit.

The Ksh800,000 cover comprises Ksh400,000 under the Social Health Insurance Fund (SHIF) and another Ksh400,000 under the Emergency, Chronic and Critical Illness Fund (ECCIF).

SHA explained that hospitals previously charged different prices for similar cancer treatments, resulting in varying costs and, in some cases, patients exhausting their benefits before completing treatment.

“The revised system aims to ensure patients receive appropriate treatment at standardised rates while maximising the enhanced oncology benefit of KES 800,000, comprising KES 400,000 under SHIF and KES 400,000 under ECCIF,” Dr Mwangangi explained.

She further noted that changes were developed through consultations led by the Ministry of Health’s National Cancer Control Programme, involving oncologists, pharmacists, nurses, public and private healthcare providers and relevant associations.

However, access to the oncology benefit is subject to approved treatment guidelines, tariffs and eligibility requirements.

“Patients are advised that access to the oncology benefit is subject to the applicable treatment guidelines, approved tariffs and eligibility requirements.

In brief

The Social Health Authority (SHA) says cancer patients will continue receiving treatment cover of up to Ksh800,000 despite recent changes to treatment approvals. However, access to the oncology benefit is subject to approved treatment guidelines, tariffs and eligibility requirements. “Patients are advised that access to the oncology benefit is subject to the applicable treatment guidelines, approved tariffs and eligibility requirements.

This is the opening of the story, shared with credit to KBC. The rest of the report — with every detail — continues on the publisher’s website.

Continue reading at KBC ↗

Cookie settings

Choose which cookies we may use. You can change this at any time from Cookie settings in the footer. Details of each cookie are in the Cookie Policy.

Strictly necessary

Needed for sign-in, security, payments and remembering these choices. Always on.

Preferences

Remember settings such as dark mode.

Analytics & performance

Help us count visits, understand which pages, devices and countries our readers use, and measure how well the site performs – anonymous and aggregated.

Advertising & marketing

Lets advertising partners show and personalise adverts, measure impressions, clicks and visits, prevent ad fraud and pay us – this is how the free site is funded.

🔔 News notifications

Get headlines from NewsHub on this device — even when the site is closed.

You can switch this off at any time. Works on Android, Windows, Mac and Linux browsers; on iPhone/iPad add the site to your Home Screen first.